Id family of helix-loop-helix proteins in cancer

Nature Reviews Cancer

Volumn 5, Issue 8, 2005, Pages 603-614

  Perk, Jonathan ^a   Iavarone, Antonio ^b   Benezra, Robert ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INHIBITOR OF DIFFERENTIATION 4; ONCOPROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENOTYPE; HUMAN; KNOCKOUT MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANAPLASIA; CELL PROLIFERATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MODELS, ANIMAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 23144464750     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1673     Document Type: Review

References (126)

1. Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410-418 (2003).
2. Norton, J. D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897-3905 (2000).
3. Yokota, Y. & Mori, S. Role of Id family proteins in growth control. J. Cell Physiol. 190, 21-28 (2002).
4. Van, W. et al. High incidence of T-cell tumors in E24-null mice and E2A/Id1 double-knockout mice. Mol. Cell Biol. 17, 7317-7327 (1997).
5. Lasorella, A., Noseda, M., Beyna, M., Yokota, Y. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407, 592-598 (2000). This paper demonstrates genetically that Id2 is a Rb target.
6. INK4a expression during cellular senescence. Nature 409, 1067-1070 (2001). This study showed that Id proteins might drive cell proliferation by inhibiting Ets induction of Ink4a.
7. Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670-677 (1999). This paper shows that complete loss of both Id1 and Id3 in the mouse, leads to premature neural differentiation; partial loss of function confers growth resistance to certain injected tumors by loss of tumour vascular integrity.
8. Mori, S., Nishikawa, S. I. & Yokota, Y. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J. 19, 5772-5781 (2000).
9. Russell, R. G., Lasorella, A., Dettin, L. E. & Iavarone, A. Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res. 64, 7220-7225 (2004).
10. Casula, M. et al. Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21. Melanoma Res. 13, 571-579 (2003).
11. Arnold, J. M., Mok, S. C., Purdie, D. & Chenevix-Trench, G. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas. Br. J. Cancer 84, 352-359 (2001).
12. Bellido, M. et al. Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia. Haematologica 88, 994-1001 (2003).
13. Fong, S., Debs, R. J. & Desprez, P. Y. Id genes and proteins as promising targets in cancer therapy. Trends Mol. Med. 10, 387-392 (2004).
14. Han, S. et al. Expression and significances of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett. 216, 63-71 (2004).
15. Wang, Q. et al. Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker. Anticancer Res. 24, 881-886 (2004).
16. Ishiguro, A. et al. Expression of Id2 and Id3 mRNA in human lymphocytes. Leuk. Res. 19, 989-996 (1995).
17. de Candia, P. et al. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc. Natl Acad. Sci. USA 100, 12337-12342 (2003).
18. Schoppmann, S. F. et al. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104, 677-682 (2003).
19. Li, H., Gerald, W. L. & Benezra, R. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Cancer Res. 64, 6137-6143 (2004).
20. Ouyang, X. S., Wang, X., Lee, D. T., Tsao, S. W. & Wong, Y. C. Over expression of ID-1 in prostate cancer. J. Urol. 167, 2598-2602 (2002).
21. Raetz, E. A. et al. Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer 98, 841-853 (2003).
22. Wang, Q. et al. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Cancer Res. 63, 1631-1635 (2003).
23. Vandesompele, J. et al. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene 22, 456-460 (2003).
24. Lopez-Carballo, G., Moreno, L., Masia, S., Perez, P. & Barettino, D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 277, 25297-25304 (2002).
25. 3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway. Biochem. Pharmacol. 65, 1943-1955 (2003).
26. Lasorella, A., Rothschild, G., Yokota, Y., Russell, R. G. & Iavarone, A. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol. Cell Biol. 25, 3563-3574 (2005).
27. Sato, Y. et al. Expression of Id2 mRNA in neuroblastoma and normal ganglion. Eur. J. Surg. Oncol. 29, 284-287 (2003).
28. Gebauer, S., Yu, A. L, Omura-Minamisawa, M., Batova, A. & Diccianni, M. B. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer 41, 297-308 (2004).
29. Tournay, O. & Benezra, R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol. Cell Biol. 16, 2418-2430 (1996).
30. Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nature Immunol. 2, 165-171 (2001).
31. Swarbrick, A. et al. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24, 381-389 (2005).
32. Light, W., Vernon, A. E., Lasorella, A., Iavarone, A. & Labonne, C. Xenopus Id3 is required downstream of Myc for the formation of multipotent neural crest progenitor cells. Development 132, 1831-1841 (2005).
33. Nilsson, J. A. et al. Id2 is dispensable for Myc-induced lymphomagenesis. Cancer Res. 64, 7296-7301 (2004).
34. Murphy, D. J., Swigart, L. B., Israel, M. A. & Evan, G. I. Id2 is dispensable for Myc-induced epidermal neoplasia. Mol. Cell Biol. 24, 2083-2090 (2004).
35. Nishimori, H. et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21, 8302-8309 (2002).
36. Fukuma, M., Okita, H., Hata, J. & Umezawa, A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene 22, 1-9 (2003).
37. Wilson, J. W. et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61, 8803-8810 (2001).
38. Weisz, L. et al. Transactivation of the EGR1 gene contributes to mutant p53 gain of function. Cancer Res. 64, 8318-8327 (2004).
39. Jen, Y., Weintraub, H. & Benezra, R. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6, 1466-1479 (1992).
40. Kreider, B. L., Benezra, R., Rovera, G. & Kadesch, T. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255, 1700-1702 (1992).
41. Shoji, W., Yamamoto, T. & Obinata, M. The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells. J. Biol. Chem. 269, 5078-5084 (1994).
42. Cai, L., Morrow, E. M. & Cepko, C. L. Misexpression of basic helix-loop-helix genes in the murine cerebral cortex affects cell fate choices and neuronal survival. Development 127, 3021-3030 (2000).
43. Martinsen, B. J. & Bronner-Fraser, M. Neural crest specification regulated by the helix-loop-helix repressor Id2. Science 281, 988-991 (1998).
44. Sun, X. H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79, 893-900 (1994). In vivo demonstration of the involvment of Id1 in differentiation and tumorigenesis.
45. Heemskerk, M. H. et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186, 1597-1602 (1997).
46. Al-Hajj, M. & Clarke, M. F. Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004).
47. Ying, Q. L., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292 (2003). Id proteins maintain the self-renewal of mouse embryonic stem cells by inhibiting neural differentiation.
48. Fraidenraich, D. et al. Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells. Science 306, 247-252 (2004).
49. Hara, E. et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269, 2139-2145 (1994).
50. Barone, M. V., Pepperkok, R., Peverali, F. A. & Philipson, L. Id proteins control growth induction in mammalian cells. Proc. Natl Acad. Sci. USA 91, 4985-4988 (1994).
51. Norton, J. D. & Atherton, G. T. Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell Biol. 18, 2371-2381 (1998).
52. Alani, R. M. et al. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl Acad. Sci. USA 98, 9637-9641 (1999).
53. Nickoloff, B. J. et al. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275, 27501-27504 (2000).
54. Tang, J., Gordon, G. M., Nickoloff, B. J. & Foreman, K. E. The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells. Lab Invest. 82, 1073-1079 (2002).
55. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
56. Prabhu, S., Ignatova, A., Park, S. T. & Sun, X. H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell Biol. 17, 5888-5896 (1997).
57. Everly, D. N., Jr., Mainou, B. A. & Raab-Traub, N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J. Virol. 78, 13470-13478 (2004).
58. Li, H. M. et al. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23, 4488-4494 (2004).
59. Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Rev. Cancer 3, 807-821 (2003).
60. Alani, R. M., Young, A. Z. & Shifflett, C. B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl Acad. Sci. USA 98, 7812-7816 (2001)
61. Zheng, W., Wang, H., Xue, L., Zhang, Z. & Tong, T. Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast. J. Biol. Chem. 279, 31524-31532 (2004).
62. Kee, Y. & Bronner-Fraser, M. To proliferate or to die: role of Id3 in cell cycle progression and survival of neural crest progenitors. Genes Dev. 19, 744-755 (2005).
63. Hata, K., Yoshimoto, T. & Mizuguchi, J. CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J. Immunol. 173, 2453-2461 (2004).
64. Iavarone, A. et al. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 432, 1040-1045 (2004).
65. Toma, J. G., El-Bizri, H., Barnabe-Heider, F., Aloyz, R. & Miller, F. D. Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis. J. Neurosci. 20, 7648-7656 (2000).
66. Desprez, P. Y., Hara, E., Bissell, M. J. & Campisi, J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. Cell Biol. 15, 3398-3404 (1995).
67. Forg, S. et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl Acad. Sci. USA 100, 13543-13548 (2003).
68. Desprez, P. Y. et al. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell Biol. 18, 4577-4588 (1998).
69. Hassskarl, J., Duensing, S., Manuel, E. & Munger, K. The helix-loop-helix protein ID1 localizes to centrosomes and rapidly induces abnormal centrosome numbers. Oncogene 23, 1930-1938 (2004).
70. Sherr, C. J. Principles of tumor suppression. Cell 116, 235-246 (2004).
71. Zheng, J., Kalkum, M., Yamamura, S., Chait, B. T. & Roeder, R. G. E protein silencing by the leukemogenic AML1-ETO fusion protein. Science 305, 1286-1289 (2004).
72. + cells, allowing nerve growth factor-induced expansion. Proc. Natl Acad. Sci. USA 102, 4016-1021 (2005).
73. Ap an, P. D. et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 16, 2408-2419 (1997).
74. Chervinsky, D. S. et al. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol. Cell Biol. 19, 5025-5035 (1999).
75. O'Neil, J., Billa, M., Oikemus, S. & Kelliher, M. The DNA binding activity of TAL-1 is not required to induce leukemia/ lymphoma in mice. Oncogene 20, 3897-3905 (2001).
76. Wice, B. M. & Gordon, J. I. Forced expression of Id-1 in the adult mouse small intestinal epithelium is associated with development of adenomas. J. Biol. Chem. 273, 25310-25319 (1998).
77. Kim, D., Peng, X. C. & Sun, X. H. Massive apoptosis of thymocytes in T-cell-deflcient Id1 transgenic mice. Mol. Cell Biol. 19, 8240-8253 (1999).
78. Morrow, M. A., Mayer, E. W., Perez, C. A., Adlam, M. & Ski, G. Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol. Immunol. 36, 491-503 (1999).
79. Ruzinova, M. B. et al. Effect of angiogenesis inhibition by Id oss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4, 277-289 (2003). Effects of Id loss on vasculature of spontaneously arising tumors are dependent on tumour type.
80. Marino, S., Romelfanger, C., Yokota, Y. & Nusse, R. Wnt1 is epistatic to Id2 in inducing mammary hyperplasia, ductal side-branching, and tumors in the mouse. BMC Cancer 4, 91 (2004).
81. Beger, C. et al. Identification of Id4 as a regulator of BPCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc. Natl Acad. Sci. USA 98, 130-135 (2001).
82. Welcsh, P. L. et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl Acad. Sci. USA 99, 7560-7565 (2002).
83. Chan, A. S. et al. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene 22, 6946-6953 (2003).
84. Umetani, N. et al. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin. Cancer Res. 10, 7475-7483 (2004).
85. Yu, L. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature Genet. 37, 265-274 (2005).
86. Skder, H. et al. Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell 4, 291-299 (2003).
87. Mechtcheriakova, D., Wlachos, A., Holzmuller, H., Binder, B. R. & Hofer, E. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 93, 3811-3823 (1999).
88. Mechtcheriakova, D. et al. Specificity, diversity, and convergence in VEGF and TNF-α signaling events leading tc tissue factor up-regulation via EGR-1 in endothelial cells. FASAB J. 15, 230-242 (2001).
89. Benezra, R. Role of Id proteins in embryonic and tumor angiogenesis. Trends Cardiovasc. Med. 11, 237-241 (2001).
90. Pammer, J., Reinisch, C., Kaun, C., Tschachler, E. & Wojta, J. Inhibitors of differentiation/DNA binding proteins Id1 and Ic3 are regulated by statins in endothelial cells. Endothelium 11, 175-180 (2004).
91. Sakurai, D. et al. Crucial role of inhibitor of DNA binding/ differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J. Immunol. 173, 5801-5809 (2004).
92. Berg, T. Modulation of protein-protein interactions with small organic molecules. Angew. Chem. Int. Ed. Engl. 42, 2462-2481 (2003).
93. Berg, T. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA 99, 3830-3835 (2002).
94. Emami, K. H. et al. A small molecule inhibitor of β-catenin/ CREB-binding protein transcription [corrected]. Proc. Natl Acad. Sci. USA 101, 12682-12687 (2004).
95. Erickson, J. W. & Cline, T. W. A bZIP protein, sisterless-a, collaborates with bHLH transcription factors early in Drosophila development to determine sex. Genes Dev. 7, 1688-1702 (1993).
96. Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 7, 1194-1201 (2001).
97. Gothert, J. R. et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104, 1769-1777 (2004).
98. Peters, B. A. et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nature Med. 11, 261-262 (2005).
99. Nikolopoulos, S. N., Blaikie, P., Yoshioka, T., Guo, W. & Giancotti, F. G. Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6, 471-483 (2004).
100. Volpert, O. V. et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2, 473-483 (2002).
101. Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med. 10, 858-864 (2004).
102. Yokota, Y. et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397, 702-706 (1999).
103. Hacker, C. et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nature Immunol. 4, 380-386 (2003).
104. + dendritic cell subset in Id2-deficient mice. J. Allergy Clin. Immunol. 111, 136-142 (2003).
105. Aoki, Y. et al. Id2 haploinsufficiency in mice leads to congenital hydronephrosis resembling that in humans. Genes Cells 9, 1287-1296 (2004).
106. Pan, L., Sato, S., Frederick, J. P., Sun, X. H. & Zhuang, Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell Biol. 19, 5969-5980 (1999).
107. Rivera, R. R., Johns, C. P., Quan, J., Johnson, R. S. & Murre, C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12, 17-26 (2000).
108. Yun, K., Mantani, A., Garel, S., Rubenstein, J. & Israel, M. A. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 131, 5441-5448 (2004).
109. Bedford, L. et al. Id4 is required for the correct timing of neural differentiation. Dev. Biol. 280, 386-395 (2005).
110. Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U. & Nordheim, A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J. Biol. Chem. 274, 19838-19845 (1999).
111. Samanta, J. & Kessler, J. A. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131, 4131-4142 (2004).
112. Nakashima, K. et al. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl Acad. Sci. USA 98, 5868-5873 (2001).
113. Katagiri, T. et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127, 1755-1766 (1994).
114. Lopez-Rovira, T., Chalaux, E., Massague, J., Rosa, J. L. & Ventura, F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277, 3176-3185 (2002).
115. Ogata, T., Wozney, J. M., Benezra, R. & Noda, M. Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc. Natl Acad. Sci. USA 90, 9219-9222 (1993).
116. Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H. & Moustakas, A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol. Cell Biol. 24, 4241-4254 (2004).
117. Kang, Y., Chen, C. R. & Massague, J. A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11, 915-926 (2003).
118. Goumans, M. J. et al. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743-1753 (2002).
119. Sugai, M., Gonda, H., Nambu, Y., Yokota, Y. & Shimizu, A. Role of Id proteins in B lymphocyte activation: new insights from knockout mouse studies. J. Mol. Med. 82, 592-599 (2004).
120. Kee, B. L., Rivera, R. R. & Murre, C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nature Immunol. 2, 242-247 (2001).
121. Rockman, S. P. et al. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 276, 45113-45119 (2001).
122. Belletti, B. et al. Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor. Exp. Cell Res. 277, 107-118 (2002).
123. Belletti, B. et al. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by hosphatidylinositol 3-kinase. J. Biol. Chem. 276, 13867-13874 (2001).
124. Bettini, M., Xi, H., Milbrandt, J. & Kersh, G. J. Thymocyte development in early growth response gene 1-deficient mice. J. Immunol. 169, 1713-1720 (2002).
125. Scobey, M. J., Fix, C. A. & Walker, W. H. The Id2 transcriptional repressor is induced by follicle-stimulating hormone and cAMP. J. Biol. Chem. 279, 16064-16070 (2004).
126. Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature (in the press).